Proposed Rule2022-18558
Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories; Extension of Comment Period
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 29, 2022
Effective
July 26, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Medicare & Medicaid Services
Abstract
The Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS) announce the extension of the comment period for the proposed rule entitled "Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories."
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 166 (Monday, August 29, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 166 (Monday, August 29, 2022)]
[Proposed Rules]
[Pages 52712-52713]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-18558]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Part 493
[CMS-3326-N]
RIN 0938-AT47
Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees;
Histocompatibility, Personnel, and Alternative Sanctions for
Certificate of Waiver Laboratories; Extension of Comment Period
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS; Centers
for Disease Control and Prevention (CDC), HHS.
ACTION: Proposed rule; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) and the
Centers for Disease Control and Prevention (CDC) within the Department
of Health and Human Services (HHS) announce the extension of the
comment period for the proposed rule entitled ``Clinical Laboratory
Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility,
Personnel, and Alternative Sanctions for Certificate of Waiver
Laboratories.''
DATES: The comment period for the proposed rule published July 26, 2022
(87 FR 44896), is extended through September 26, 2022.
ADDRESSES: In commenting, please refer to file code CMS-3326-P.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-3326-P, P.O. Box 8016,
Baltimore, MD 21244-8016.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-3326-P, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
FOR FURTHER INFORMATION CONTACT: Sarah Bennett, CMS, (410) 786-3531,
Serafina Brea, CMS, (410) 786-3531, or Heather Stang, CDC, 404-498-
2769.
SUPPLEMENTARY INFORMATION: In the ``Clinical Laboratory Improvement
Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and
Alternative Sanctions for Certificate of Waiver Laboratories'' proposed
rule that appeared in the July 26, 2022 Federal Register (87 FR 44896),
we solicited public comments on proposed changes to CLIA fees,
histocompatibility and personnel requirements, and alternative
sanctions for Certificate of Waiver laboratories.
In response to requests we received from several laboratory
professional organizations, we are extending the comment period an
additional 30 days. This extension will maximize the opportunity for
the public to provide
[[Page 52713]]
meaningful input to CMS and CDC) for an additional 30 days.
Dated: August 24, 2022.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2022-18558 Filed 8-24-22; 4:15 pm]
BILLING CODE 4120-01-P
</pre></body>
</html>Indexed from Federal Register on August 29, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.